ED Pde 5i denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for ed pde5i are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Your PDE5 Inhibitor for Step Therapy

A step-therapy denial — sometimes called "fail-first" — means Cigna requires you to try and document an inadequate response to one or more preferred formulary agents within the PDE5 inhibitor class before it will authorize the specific agent your prescriber requested. Cigna's policy typically designates one or more generic PDE5 inhibitors as the required first-step agents. If your prescriber went straight to a non-preferred or brand-name agent, the step requirement was not satisfied in Cigna's records, triggering the denial.

## Why This Denial Is Appealable

Step-therapy requirements are not absolute. All major commercial insurers, including Cigna, have step-therapy exception processes that allow bypass of the step requirement when a prescriber documents a valid clinical reason — prior failure of the required step agent, a contraindication, or a patient-specific clinical factor that makes the step agent inappropriate. Many states also have enacted step-therapy override laws that impose strict timelines on insurers to respond to exception requests. If you have already tried the required agent and it was ineffective or not tolerated, documenting that history is sufficient to satisfy the step requirement. If you have a clinical reason to start with the requested agent directly, your prescriber's letter is the key document.

## Federal Appeal Framework

ACA Section 2719 guarantees external review by an accredited IRO once internal appeals are exhausted. ERISA Section 503 provides full-and-fair review rights for employer-sponsored plans with written reasoning at every level. The external review window is approximately 4 months from the final internal denial. Expedited review (72 hours) is available when delay would seriously jeopardize your health.

## Concrete Appeal Steps and Timeline

1. Identify the required step agent(s) — obtain Cigna's step-therapy criteria from the denial letter or by calling Cigna's PA line. 2. If you previously tried the step agent: gather pharmacy records, prescriber notes, and any documentation of the inadequate response or adverse effect with dates. 3. If you have not tried the step agent: ask your prescriber to document why skipping the step is clinically appropriate for you specifically. 4. File the step-therapy exception request and internal appeal together, within the EOB deadline. 5. Escalate to external review if Cigna upholds the denial after internal review.

## Documentation to Gather

• Diagnosis confirmation: Chart notes with an ED diagnosis and relevant clinical context.
• Step-agent trial history: Pharmacy records and prescriber notes documenting prior use of the required first-line agent(s), dates, and the reason the step agent was inadequate or discontinued.
• Step-exception clinical rationale: If bypassing the step, a detailed prescriber letter explaining the patient-specific clinical reason the step agent is contraindicated or otherwise clinically inappropriate.
• Prescriber medical-necessity letter: Addresses both the step-therapy exception and the overall medical necessity for the requested agent.
• Criteria-mapping table: Obtain Cigna's step-therapy policy and exception criteria, list each requirement, and provide the exact chart fact that satisfies each row. This structured mapping is the most effective tool for overturning step-therapy denials.